We’re honored to have accompanied Ibex on this journey — providing comprehensive statistical study design, clinical data management, and site monitoring services. From shaping study protocols to supporting regulatory submissions, our team collaborated closely with Ibex to ensure the highest scientific and operational standards were met.
Designed to enhance diagnostic accuracy in prostate cancer detection, this groundbreaking solution marks a significant step forward in harnessing AI to support pathologists and improve patient outcomes.
“Collaboration is at the heart of every breakthrough, and Bioforum’s expertise and dedication made them an invaluable partner,” noted Manuela Vecsler, VP Clinical & Scientific Affairs at Ibex. “Their professionalism and flexibility helped us achieve this important milestone.”
By empowering pathologists with an extra layer of clinical insight, Ibex’s innovative technology can be used to help deliver faster, more consistent, and accurate cancer diagnoses. The potential impact on patients and healthcare systems is profound, and we’re proud to have played a role in bringing this transformative solution to market”.